XML 18 R21.htm IDEA: XBRL DOCUMENT

Entity Wide Disclosures

3 Months Ended

Mar. 31, 2020

(13) Entity Wide Disclosures

Revenue by Category

The following table disaggregates our revenue by major source (in thousands):

	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Therapeutic Area
Oncology	$	69,212	$	55,962
Other		50,569		46,869
Metabolic		36,075		35,001
Cardiology		25,899		22,650
AVAI		25,147		19,924
Central Nervous System		23,977		20,335
Total revenue	$	230,879	$	200,741

In the current quarter and for all periods presented, the revenue associated with medical device projects, previously a separate therapeutic area, has been included in the respective therapeutic area that best aligns with the therapeutic focus of the medical device project and represents how management evaluates disaggregated revenue in its internal reporting.